Industry

Healthcare

11 articles on Healthcare.

Japan Drug Pricing: A Guide to MHLW Policy & Trends
Japan Drug Pricing: A Guide to MHLW Policy & Trends

Navigate Japan's complex pharmaceutical market with our expert guide. Understand the core challenges of the MHLW-led drug pricing system, key repricing rules like Market Expansion Repricing, and major policy trends to watch.

Regulatory Intelligence Pharma | AI Supply Chain Monitoring
Regulatory Intelligence Pharma | AI Supply Chain Monitoring

Supply Chain Resilience Secure Your Pharmaceutical Supply Chain in an Unstable World Your access to critical Active Pharmaceutical Ingredients (APIs) is under constant threat from geopolitical instability, sudden export controls, and complex regulatory shifts. It’s time to move from reactive crisis management to proactive supply chain resilience. Policy-Insider.AI provides the AI-powered regulatory intelligence pharma companies […]

Pharma Market Access Intelligence
Pharma Market Access Intelligence

Strategic Advantage Decode Policy. Secure Access. Lead the Market. In the high-stakes world of pharma, market access is everything. But the policy landscape for pricing, reimbursement, and regulation is always changing. Policy-Insider.AI delivers proactive regulatory intelligence for pharma. We transform unstructured public information into a clear strategic advantage, so you can stop reacting and start […]

China API Export Monitoring: A Guide for US Pharma
China API Export Monitoring: A Guide for US Pharma

US pharma faces growing risks from Chinese API dependency. This guide explains why traditional methods fail and outlines a proactive framework for China API export monitoring across regulatory, political, and market signals to protect your supply chain.

Patient Advocacy & GLP-1 Access: A Shifting Landscape
Patient Advocacy & GLP-1 Access: A Shifting Landscape

The rise of GLP-1s has fractured the patient advocacy landscape, creating new risks and opportunities for pharma. This case study analyzes the key advocacy archetypes shaping GLP-1 access policy and explains why dynamic, AI-driven intelligence is now essential.

Beyond the Matrix: Why Traditional Stakeholder Mapping Fails in EU Pharma Policy
Beyond the Matrix: Why Traditional Stakeholder Mapping Fails in EU Pharma Policy

Discover why traditional stakeholder matrix mapping is a dangerously outdated tool for navigating the complex world of EU pharmaceutical policy. Learn how its static nature creates blind spots and why a shift to dynamic, AI-powered stakeholder intelligence is essential for success.

LkSG to CSDDD: German & EU Supply Chain Due Diligence Guide
LkSG to CSDDD: German & EU Supply Chain Due Diligence Guide

This guide explains Germany's Supply Chain Act (LkSG) and the EU's Corporate Sustainability Due Diligence Directive (CSDDD). Learn who these laws apply to, what they require, and how they differ to ensure your business remains compliant.

Automated Position Paper Validation: Keep Your Strategy Aligned with Policy Shifts
Automated Position Paper Validation: Keep Your Strategy Aligned with Policy Shifts

Stop defending outdated positions. Policy-Insider.AI offers automated position paper validation, continuously testing your strategy against real-world policy, stakeholder, and media signals. Turn your static document into a proactive advocacy tool.

What is a Stakeholder? A Complete Definition & Guide
What is a Stakeholder? A Complete Definition & Guide

A modern definition and practical guide to stakeholders for public affairs: classification frameworks, mapping, management, and why AI-native stakeholder intelligence is replacing spreadsheets.

Stakeholder Intelligence for Pharma
Stakeholder Intelligence for Pharma

Stop reacting and start anticipating. Policy-Insider.AI offers an AI-native stakeholder intelligence system for pharma, transforming public information into decision-ready insights for your public affairs and market access teams.

Tell us what you need to monitor

No spam. No automatic sign-up. We will contact you directly to discuss your setup.